Jace Jianxin HUANG in

Jace Jianxin HUANG

Login to view DISC.
Senior Director, Oncology Early Commercial & Portfolio Strategy at GSK
📍 Cambridge, Massachusetts, United States

Jace Jianxin Huang is the Senior Director of Oncology Early Commercial & Portfolio Strategy at GSK, with deep expertise in leading global product launches across the U. S. , Europe, and China. He holds dual MBAs from HEC Paris and Georgetown University and is certified in European Pharma Market Access.

He has a strong interest in technologys role in healthcare, particularly the application of AI in diagnosing rare cancers and diseases. He is also passionate about improving patient access to medication and has voiced concerns about drug affordability.

At his previous role at Ipsen, he led the commercial assessment for the license-in of Elafibrarnor, which was the companys largest transaction.

Read the full overview →
Experience
18 Years
Current Role
Senior Director, Oncology Early Commercial & Portfolio Strategy
Job Level
Senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Jace shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Jace cares about

Oncology Innovation
He is impressed by the volume and depth of innovation in cancer care, including next-gen targeted therapies, ADCs, and TCEs, reflecting his current focus at GSK.
Rare Disease Advocacy
He has a significant background in rare diseases from his time at Ipsen and expresses genuine pride in the progress being made for these patients.
+5 more topics Login to view topics
Career

Work history

11-2023
Senior Director, Oncology Early Commercial & Portfolio Strategy
GSK
4-2022 - 4-2023
Acting Chief Of Staff and Head of Operations, US Neuroscience Franchise
Ipsen
11-2020 - 9-2023
Global Head of New Product Planning & Endocrinology Strategy - Rare Diseases
Ipsen
1-2020 - 11-2020
Global Head of Pediatric Endocrinology & Global Commercial Director- Rare Diseases
Ipsen
3-2018 - 12-2019
Global Commercial Director - Oncology
Ipsen
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2013 - 2015
Master of Business Administration (MBA)
HEC Paris
2014 - 2014
Master of Business Administration (MBA)
Georgetown University McDonough School of Business
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other GSK Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Jace. Free, 10 seconds.